Impact of delay neoadjuvant chemotherapy on pathologic complete response in locally advanced breast cancer evidence of the real world in Mexico

被引：0
|
作者：
Cabrera, P. [1 ]
Munoz, W. [1 ]
Gutierrez, L. [1 ]
Ramirez, M. T. [1 ]
Albarado, A. [1 ]
Lara, F. [1 ]
Mohar, A. [1 ]
机构：
[1] Natl Canc Inst Mexico, Mexico City, DF, Mexico
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P5-08-22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-08-22
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prediction of pathologic complete response to neoadjuvant chemoradiation in locally advanced rectal cancer
    Zhong, Xiaoling
    Zeng, Guohua
    Zhang, Lixiang
    You, Shuyuan
    Fu, Yuxiang
    He, Wan
    Liao, Guixiang
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI
    Nannan Lu
    Jie Dong
    Xin Fang
    Lufang Wang
    Wei Jia
    Qiong Zhou
    Lingyu Wang
    Jie Wei
    Yueyin Pan
    Xinghua Han
    BMC Medical Imaging, 21
  • [23] Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI
    Lu, Nannan
    Dong, Jie
    Fang, Xin
    Wang, Lufang
    Jia, Wei
    Zhou, Qiong
    Wang, Lingyu
    Wei, Jie
    Pan, Yueyin
    Han, Xinghua
    BMC MEDICAL IMAGING, 2021, 21 (01)
  • [24] Assessment of biomarker expression in predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Chhieng, David C.
    Rodriguez-Burford, Cristina
    Meleth, Sreelatha
    Grizzle, William E.
    Ferguson, Susan M.
    BREAST JOURNAL, 2007, 13 (05): : 534 - 535
  • [25] The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer
    Ajmani, Gaurav S.
    James, Ted A.
    Kantor, Olga
    Wang, Chi-Hsiung
    Yao, Katharine A.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (11) : 3157 - 3166
  • [26] The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer
    Gaurav S. Ajmani
    Ted A. James
    Olga Kantor
    Chi-Hsiung Wang
    Katharine A. Yao
    Annals of Surgical Oncology, 2017, 24 : 3157 - 3166
  • [27] The impact of tumor microenviroment on pathologic complete response after neoadjuvant chemotherapy of early breast cancer
    Kuhar, C. Grasic
    Gazic, B.
    Ivancic, A. Klevisar
    Drev, P.
    Vetter, M. H. F.
    Kurzeder, C.
    Gersak, K.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S611 - S611
  • [28] Combined Neoadjuvant Chemotherapy With Bevacizumab Improves Pathologic Complete Response in Patients With Hormone Receptor Negative Operable or Locally Advanced Breast Cancer
    Makhoul, Issam
    Klimberg, Vicki Suzanne
    Korourian, Soheila
    Henry-Tillman, Ronda S.
    Siegel, Eric R.
    Westbrook, Kent C.
    Hutchins, Laura F.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (01): : 74 - 79
  • [29] Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer
    Kahan, Zsuzsanna
    BREAST CANCER MANAGEMENT, 2013, 2 (04) : 274 - 274
  • [30] Pathologic complete response is an independent prognostic factor for locoregional recurrence in locally advanced breast cancer patients after neoadjuvant chemotherapy.
    Chou, Hsu-Huan
    Chen, Shin-Che
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 65 - 66
12345